Pharmacology Study Notes: Acetaminophen, Activated Charcoal, Albuterol, Aspirin, Dextrose, and Epinephrine

Acetaminophen (Tylenol)

  • Class: Non-narcotic analgesic, antipyretic
  • Action: Inhibits the enzyme cyclooxygenase. Increases pain threshold in the CNS.
  • Indication: Pain, fever
  • Contraindications: Hypersensitivity. Patients with liver disease, severe hepatic impairment
  • Precautions: Patients with history of hepatic complications
  • Side Effects: Dizziness, lethargy, GI distress, diarrhea, hepatic failure, renal failure, diaphoresis (minimal in therapeutic doses)
  • Interactions: Chronic alcohol use can increase the liver toxicity of acetaminophen
  • Dose & Route:
    • Adult: 325650mg325\text{--}650\,\text{mg} PO every 46hours4\text{--}6\,\text{hours} MAX 1g/dose1\,\text{g/dose}
    • Adult (>50kg>50\,\text{kg}): 1g1\,\text{g} every 6hours6\,\text{hours} IV
    • Adult (<50kg<50\,\text{kg}): 15mg/kg15\,\text{mg/kg} every 6hours6\,\text{hours} IV
    • Pediatric: 1015mg/kg10\text{--}15\,\text{mg/kg} PO every 46hours4\text{--}6\,\text{hours}
    • Pediatric (212yo2\text{--}12\,\text{yo}): Same as adult IV
  • Onset & Duration:
    • Onset: 1530minutes15\text{--}30\,\text{minutes}
    • Duration: 34hours3\text{--}4\,\text{hours}

Activated Charcoal (Actidose)

  • Class: Absorbent
  • Action: Binds with ingested toxins in the GI tract to prevent absorption
  • Indications: Oral ingestion of toxins; most commonly pills of ingested toxins
  • Contraindications: AMS or risk of aspiration, ingestion of corrosives, caustics or petroleum distillates
  • Precautions: Not specified
  • Side Effects: Black tarry stool, constipation, moderate to severe nausea and vomiting
  • Interactions: Will inactivate other oral medications
  • Dose & Route:
    • Form: Premixed slurry bottle
    • Adult & Pediatric: 1g/kg1\,\text{g/kg} PO
  • Onset & Duration:
    • Onset: Varies
    • Duration: Until digested in the GI tract

Albuterol (Proventil, Ventolin)

  • Class: Sympathomimetic Bronchodilator
  • Action: Selective B2 agonist that stimulates adrenergic beta 2 receptors of the SNS, causing smooth muscle relaxation in the bronchial tree (bronchodilation) and decreased airway resistance
  • Indication: Bronchospasm in COPD/Asthma. Crush injury/hyperkalemia
  • Contraindication: Hypersensitivity. Symptomatic tachydysrhythmias, pulmonary edema (if used as primary treatment). Synergistic with other sympathomimetics
  • Precautions: Heart disease. ECG that shows cardiac ischemia, severe HTN, tachydysrhythmias
  • Side Effects: Tachycardia, palpitations, wheezing, hypertension, anxiety, nervousness, tremors, nausea, vomiting, heartburn, arrhythmias, chest pain, headache, coughing
  • Interactions: Tricyclic antidepressants may potentiate vasculature effects. Beta blockers are antagonistic. May potentiate hyperkalemia caused by diuretics
  • Dose & Route:
    • Adult (Bronchospasm): 2.55.0mg2.5\text{--}5.0\,\text{mg} nebulized
    • Adult (Crush injury/Hyperkalemia): 1020mg10\text{--}20\,\text{mg} nebulized
    • Pediatric: 2.5mg2.5\,\text{mg} nebulized
  • Onset & Duration:
    • Onset: 515min5\text{--}15\,\text{min}
    • Peak: 30min30\,\text{min}
    • Duration: 34hours3\text{--}4\,\text{hours}

Aspirin (Bayer)

  • Class: Platelet inhibitor (anti platelet aggregate), NSAID
  • Action: Inhibits platelet aggregation causing prostoglandin inhibition (thromboxane A2)
  • Indication: New onset chest pain suggestive of acute MI. Signs and symptoms suggestive of recent CVA
  • Contraindication: Hypersensitivity. Acute asthma, GI bleeding ulcers. Administered to children or adolescents with suspected viral illness (Reyes Syndrome)
  • Precautions: Hypersensitivity to other NSAIDs, fragile asthmatics, hepatic/renal impairment
  • Side Effects: Heartburn, GI bleeding, prolonged bleeding, nausea, vomiting, bronchoconstriction in allergic patients
  • Interactions: Patients allergic to NSAIDs. Seasonal allergies, liver disease, alcohol abuse, kidney disease, or coagulopathies
  • Dose & Route:
    • Adult: 160325mg160\text{--}325\,\text{mg} PO
  • Onset & Duration:
    • Onset: 1520minutes15\text{--}20\,\text{minutes}
    • Duration: 24hours24\,\text{hours}

Dextrose (D50, D25, D10)

  • Class: Carbohydrate, hypertonic solution
  • Action: Increases serum glucose levels. Short-term osmotic diuresis
  • Indication: Hypoglycemia
  • Contraindications: None in the presence of Hypoglycemia
  • Precautions: Acute stroke, intracranial hemorrhage, brain injury. Cause severe tissue necrosis with IV infiltration
  • Side Effects: Warmth, pain, burning, thrombophlebitis, rhabdomyolysis. Hyperglycemia (short lived)
  • Interactions: None in the emergency setting
  • Dose & Route:
    • D50: Prefilled syringe of 25g/50ml25\,\text{g} / 50\,\text{ml}
    • D25: 12.5g/50ml12.5\,\text{g} / 50\,\text{ml} or 25g/100ml25\,\text{g} / 100\,\text{ml}
    • D10: 25g/500ml25\,\text{g} / 500\,\text{ml}
    • Adult: 25g25\,\text{g} slow IV; repeated as necessary
    • Pediatric: 0.5g/kg/dose0.5\,\text{g/kg/dose} slow IV; repeated as necessary
  • Onset & Duration:
    • Onset: 3060seconds30\text{--}60\,\text{seconds}
    • Peak: Variable
    • Duration: Depends on severity of Hypoglycemia

Epinephrine 1:1,000 (Adrenaline)

  • Class: Sympathomimetic
  • Action: Bronchial dilation. Direct acting alpha & beta agonist
    • Alpha: Vasoconstriction
    • Beta 1: Positive Inotropic Effect (strength of contraction) INTENSITY; Chronotropic Effect (heart rate) CLOCK; Dromptropic Effect (electrical impulse) CONDUCTION
    • Beta 2: Bronchial smooth muscle relaxation & dilation of skeletal vasculature
  • Indication: Acute anaphylaxis (allergic reaction with airway involvement)
  • Contraindication: No contraindications in emergency situation
  • Precautions: Patients with underlying cardiac conditions. Increases myocardial oxygen demand, may increase myocardial ischemia
  • Side Effects: Hypertension, tachycardia, arrhythmias, pulmonary edema, anxiety, restlessness, psychomotor agitation, nausea, headache, angina
  • Interactions: Potentiates other sympathomimetic/antidepressants. Deactivated by alkaline solutions (sodium bicarbonate). Monoamine oxidase inhibitors (MAOIs) may potentiate effects. Beta blockers may blunt effects
  • Dose & Route:
    • Form: Prefilled autoinjectors, 1mg/ml1\,\text{mg/ml} vials or ampules
    • Adult: 0.30.5mg0.3\text{--}0.5\,\text{mg} IM/SC PRN every 15min15\,\text{min}
    • Pediatric: 0.01mg/kg0.01\,\text{mg/kg} up to 0.3mg0.3\,\text{mg} IM
  • Onset & Duration:
    • Onset: Immediate
    • Duration: 35min3\text{--}5\,\text{min}

Epinephrine 1:10,000 (Adrenaline)

  • Class: Sympathomimetic
  • Action: Bronchial dilation. Direct acting alpha & beta agonist
    • Alpha: Vasoconstriction
    • Beta 1: Positive Inotropic Effect (strength of contraction) INTENSITY; Chronotropic Effect (heart rate) CLOCK; Dromptropic Effect (electrical impulse) CONDUCTION
    • Beta 2: Bronchial smooth muscle relaxation & dilation of skeletal vasculature
  • Indications: Cardiac arrest; pulseless VTACH, VFIB, PEA, Asystole. Symptomatic bradycardia
  • Contraindications:
    • Cardiac Arrest: None in the emergency setting
    • Symptomatic Bradycardia: Tachyarrhythmias, pulmonary edema, hypertension, myocardial ischemia, Hypovolemic shock, hypothermia
  • Precautions: Increases myocardial oxygen demand; may potentially increase myocardial ischemia, patients with underlying cardiovascular disease
  • Side Effects: Symptomatic Bradycardia: HTN. Tachycardia, arrhythmias, pulmonary edema, anxiety restlessness
  • Interactions: Potentiates other sympathomimetic. Deactivated by sodium bicarbonate
  • Dose & Route:
    • Adult Cardiac Arrest: 1mg1\,\text{mg} 1:10,0001:10,000 IV every 35min3\text{--}5\,\text{min}
    • Adult Symptomatic Bradycardia: 210mcg/min2\text{--}10\,\text{mcg/min} or 0.10.5mcg/kg/min0.1\text{--}0.5\,\text{mcg/kg/min} (mix 1mg1\,\text{mg} for every 100ml100\,\text{ml})
    • Pediatric Cardiac Arrest: 0.01mg/kg0.01\,\text{mg/kg} IV every 35min3\text{--}5\,\text{min}
    • Pediatric Symptomatic Bradycardia: 0.01mg/kg0.01\,\text{mg/kg} IV every 35min3\text{--}5\,\text{min}
  • Onset & Duration:
    • Onset: Immediate
    • Duration: 35min3\text{--}5\,\text{min}
  • Push Dose Mix (Epi 1:10,000 Procedure):
    • Discard 1ml1\,\text{ml} of NS in 10ml10\,\text{ml} Syringe = 9ml9\,\text{ml} NS in syringe
    • Draw up 1ml1\,\text{ml} of Epi 1:10,0001:10,000 = 0.1mg/100mcg0.1\,\text{mg} / 100\,\text{mcg}
    • Syringe now contains 10ml10\,\text{ml} of Epi at 10mcg/ml10\,\text{mcg/ml} (1:100,0001:100,000)
    • Dose: 0.52ml0.5\text{--}2\,\text{ml} (520mcg5\text{--}20\,\text{mcg}) every 15min1\text{--}5\,\text{min}